VOYA Investment Management
ELOX

VOYA Investment Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

VOYA Investment Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-346
Closed -$46K – 2934
2021
Q1 		$46K Hold
346
– – ﹤0.01% 2749
2020
Q4 		$55K Buy
+346
New +$42.3K ﹤0.01% 2651
2020
Q2 		– Sell
-325
Closed -$25K – 2665
2020
Q1 		$25K Hold
325
– – ﹤0.01% 2577
2019
Q4 		$96K Buy
+325
New +$65.5K ﹤0.01% 2558

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VOYA Investment Management's ELOX Position: Q2 2021 in Review

VOYA Investment Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 346 shares — an estimated $46K sold.

VOYA Investment Management first reported a position in ELOX in Q4 2019 and held it in 4 quarters. The position peaked at $96K in Q4 2019. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • VOYA Investment Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 346 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $46K.
  • VOYA Investment Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • VOYA Investment Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $96K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.